Company Profile:
GlaxoSmithKline Pakistan Limited is a Manufacturer.
Company Introduction:
GlaxoSmithKline Pakistan Limited (GSK Pakistan) is one of the leading pharmaceutical and consumer healthcare companies operating in Pakistan. It is a subsidiary of the global pharmaceutical and healthcare group, GlaxoSmithKline (now primarily GSK plc for pharmaceuticals and vaccines, and Haleon for consumer healthcare).
GSK Pakistan functions as a manufacturer, operating multiple production facilities within Pakistan. These facilities are responsible for the local manufacturing of a broad spectrum of pharmaceutical products, vaccines, and consumer healthcare items. The company is actively involved in the research, development, manufacturing, marketing, and distribution of prescription medicines, vaccines, and over-the-counter (OTC) products across diverse therapeutic areas.
With a deep commitment to improving health and well-being, GSK Pakistan holds a significant position in the country's healthcare landscape, providing crucial medicines and healthcare solutions to the Pakistani population.
Enterprise Products
GlaxoSmithKline Pakistan produces or sells the following products:
Pharmaceuticals:
Augmentin (Amoxicillin/Clavulanic Acid)
Amoxil (Amoxicillin)
Seretide (Fluticasone Propionate/Salmeterol)
Ventolin (Salbutamol)
Flixotide (Fluticasone Propionate)
Betnovate (Betamethasone Valerate)
Paxil (Paroxetine)
Valium (Diazepam)
Zantac (Ranitidine)
Vaccines:
Infanrix Hexa (DTaP-IPV-Hib-HepB Vaccine)
Synflorix (Pneumococcal Conjugate Vaccine)
Boostrix (Tdap Vaccine)
Fluarix (Influenza Vaccine)
Engerix-B (Hepatitis B Vaccine)
Havrix (Hepatitis A Vaccine)
Rotarix (Rotavirus Vaccine)